To include your compound in the COVID-19 Resource Center, submit it here.

Gluten-free gut

How PvP’s KumaMax degrades gluten to prevent celiac disease attacks

PvP Biologics Inc. is developing an oral enzyme therapy for celiac disease to break down gluten in the stomach with more specificity than a competing enzyme cocktail. The company’s KumaMax, a synthetic peptidase, should prevent the antigen from reaching the intestine and immune system, where other competitors act.

Patients with celiac disease produce antibodies that attack dietary gluten as it passes through the intestine, causing severe intestinal damage and malnutrition. Even with a strict gluten-free diet -- currently the

Read the full 791 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE